Payer PolicyActive
MED.00092 Automated Nerve Conduction Testing
ANTHEM-MED.00092
Anthem
Effective: January 30, 2025
Updated: December 30, 2025
Policy Summary
This policy addresses automated, noninvasive nerve conduction testing devices (portable/handheld systems with automated analysis) used to perform nerve conduction studies. Anthem considers these automated nerve conduction tests investigational and not medically necessary for all indications, including when used as an alternative to standard nerve conduction studies. There are no covered indications or exceptions under this policy; conventional EMG/NCS may be assessed under separate policies.
Coverage Criteria Preview
Key requirements from the full policy
"Electrodiagnostic testing with automated, noninvasive nerve conduction testing devices is consideredinvestigationalandnot medically necessaryfor all indications, including as an alternative method ..."
Sign up to see full coverage criteria, indications, and limitations.